Economics of vaccines revisited

References

• Ethgen O, Standaert B. Population- versus cohort-based modelling approaches. Pharmacoeconomics 2012; 30:171 - 81; http://dx.doi.org/10.2165/11593050-000000000-00000; PMID: 22283692
   PubMed Web of Science ®Google Scholar
• Westra TA, Parouty M, Brouwer WB, Beutels PH, Rogoza RM, Rozenbaum MH, et al. On discounting of health gains from human papillomavirus vaccination: effects of different approaches. Value Health 2012; 15:562 - 7; http://dx.doi.org/10.1016/j.jval.2012.01.005; PMID: 22583467
   PubMed Web of Science ®Google Scholar
• Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis 2009; 200:Suppl 1 S16 - 27; http://dx.doi.org/10.1086/605026; PMID: 19817595
   PubMed Web of Science ®Google Scholar
• Farkouh RA, Klok RM, Postma MJ, Roberts CS, Strutton DR. Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions. Expert Rev Vaccines 2012; 11:1235 - 47; http://dx.doi.org/10.1586/erv.12.99; PMID: 23170992
   PubMed Web of Science ®Google Scholar
• Beutels P, Van Doorslaer E, Van Damme P, Hall J. Methodological issues and new developments in the economic evaluation of vaccines. Expert Rev Vaccines 2003; 2:649 - 60; http://dx.doi.org/10.1586/14760584.2.5.649; PMID: 14711326
   PubMedGoogle Scholar
• Postma MJ, Beardsworth P, Wilschut JC. Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes. J Med Econ 2008; 11:743 - 68; http://dx.doi.org/10.3111/13696990802505557; PMID: 19450079
   PubMedGoogle Scholar
• Drummond M, Chevat C, Lothgren M. Do we fully understand the economic value of vaccines?. Vaccine 2007; 25:5945 - 57; http://dx.doi.org/10.1016/j.vaccine.2007.04.070; PMID: 17629362
   PubMed Web of Science ®Google Scholar
• Bärnighausen T, Bloom DE, Cafiero ET, O’Brien JC. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus. Clin Microbiol Infect 2012; 18:Suppl 5 70 - 6; http://dx.doi.org/10.1111/j.1469-0691.2012.03977.x; PMID: 22882176
   PubMed Web of Science ®Google Scholar
• Smith RD, Keogh-Brown MR, Barnett T, Tait J. The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment. BMJ 2009; 339:b4571; http://dx.doi.org/10.1136/bmj.b4571; PMID: 19926697
   PubMed Web of Science ®Google Scholar
• Bobinac A, van Exel NJ, Rutten FF, Brouwer WB. VALUING QALY GAINS BY APPLYING A SOCIETAL PERSPECTIVE. Health Econ 2012; In Press http://dx.doi.org/10.1002/hec.2879; PMID: 23080321
   PubMed Web of Science ®Google Scholar
• Smith RD, Keogh-Brown MR, Barnett T. Estimating the economic impact of pandemic influenza: An application of the computable general equilibrium model to the U.K. Soc Sci Med 2011; 73:235 - 44; http://dx.doi.org/10.1016/j.socscimed.2011.05.025; PMID: 21708419
   PubMed Web of Science ®Google Scholar
• PharmacoEconomic Guidlines. 11-12-2012. Ref Type: Internet Communication, www.ispor.org/PEguidelines/index.asp
   Google Scholar
• Rozenbaum MH, Mangen MJ, Giaquinto C, Wilschut JC, Hak E, Postma MJ, Consensus Group on Dutch Rotavirus Vaccination (CoRoVa-Group). Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Public Health 2011; 11:462; http://dx.doi.org/10.1186/1471-2458-11-462; PMID: 21663620
   PubMed Web of Science ®Google Scholar
• Bilcke J, Van Damme P, Beutels P. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and “no medical care” disease impact in Belgium. Med Decis Making 2009; 29:33 - 50; http://dx.doi.org/10.1177/0272989X08324955; PMID: 18948433
   PubMed Web of Science ®Google Scholar
• Jit M, Edmunds WJ. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. [Corrected Proof.] Vaccine 2007; 25:3971 - 9; http://dx.doi.org/10.1016/j.vaccine.2007.02.070; PMID: 17400341
   PubMed Web of Science ®Google Scholar
• Standaert B, Parez N, Tehard B, Colin X, Detournay B. Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France. Appl Health Econ Health Policy 2008; 6:199 - 216; http://dx.doi.org/10.1007/BF03256134; PMID: 19382820
   PubMedGoogle Scholar
• Bilcke J, Beutels P. Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources. Pharmacoeconomics 2009; 27:281 - 97; http://dx.doi.org/10.2165/00019053-200927040-00002; PMID: 19485425
   PubMed Web of Science ®Google Scholar
• Mauskopf J, Talbird S, Standaert B. Categorization of methods used in cost-effectiveness analyses of vaccination programs based on outcomes from dynamic transmission models. Expert Rev Pharmacoecon Outcomes Res 2012; 12:357 - 71; http://dx.doi.org/10.1586/erp.12.11; PMID: 22812559
   PubMed Web of Science ®Google Scholar
• Cairns JA. Valuing future benefits. Health Econ 1994; 3:221 - 9; http://dx.doi.org/10.1002/hec.4730030404; PMID: 7994322
   PubMed Web of Science ®Google Scholar
• Demarteau N, Breuer T, Standaert B. Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program. Pharmacoeconomics 2012; 30:337 - 53; http://dx.doi.org/10.2165/11591560-000000000-00000; PMID: 22409292
   PubMed Web of Science ®Google Scholar
• Defechereux T, Paolucci F, Mirelman A, Youngkong S, Botten G, Hagen TP, et al. Health care priority setting in Norway a multicriteria decision analysis. BMC Health Serv Res 2012; 12:39; http://dx.doi.org/10.1186/1472-6963-12-39; PMID: 22335815
   PubMed Web of Science ®Google Scholar
• Baltussen R, Stolk E, Chisholm D, Aikins M. Towards a multi-criteria approach for priority setting: an application to Ghana. Health Econ 2006; 15:689 - 96; http://dx.doi.org/10.1002/hec.1092; PMID: 16491464
   PubMed Web of Science ®Google Scholar
• Bloom DE, Canning D, Hu L, Liu Y, Mahal A, Yip W. The Contribution of Population Health and Demographic Change to Economic Growth in China and India. J Comp Econ 2010; 38:17 - 33; http://dx.doi.org/10.1016/j.jce.2009.11.002; PMID: 20419074
   PubMed Web of Science ®Google Scholar
• Suhrke M, Mckee M. Re-orienting health systems. 2012. Ref Type: Report, eurohealthnet.eu/sites/eurohealthnet.eu/files/press-release/Background.pdf.
   Google Scholar
• Connolly MP, Topachevskyi O, Standaert B, Ortega O, Postma M. The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis. Pharmacoeconomics 2012; 30:681 - 95; http://dx.doi.org/10.2165/11597750-000000000-00000; PMID: 22788259
   PubMed Web of Science ®Google Scholar
• Davoodi H, Tiongson E, Asawanuchit S. Benefit Incidence of Public Education and Health Spending Worldwide: Evidence from a New Database. Poverty & Public Policy 2010; 2:191 - 238; http://dx.doi.org/10.2202/1944-2858.1055
   Google Scholar
• Kinderafdelingen ziekhuizen liggen overvol. KNACK 2012 Nov 23.
   Google Scholar